The Best of Canadian Science and Technology
Medical device company Profound Medical (Profound Medical Stock Quote, Chart, News TSX:PRN) is already up 22 per cent over the last two weeks but … [Read more...] about Profound Medical will have a transformative 2020, says Raymond James
All systems are go for Profound Medical (Profound Medical Stock Quote, Chart, News TSX:PRN), according to Raymond James analyst Rahul Sarugaser, who … [Read more...] about Profound Medical has a huge upside, Raymond James says
Paradigm Capital analyst Corey Hammill likes the long-term forecast for medical device company Profound Medical (Profound Medical Stock Quote, Chart, … [Read more...] about Profound Medical gets news $45.00 target at Paradigm
Raymond James analyst Rahul Sarugaser is staying bullish on biotech company Profound Medical Corp (Profound Medical Corp Stock Quote, Chart, News … [Read more...] about Profound Medical stock has a 204 per cent upside, says Raymond James
Canadian Life Sciences stocks have been on a roller coaster ride so far in 2019. The sector, which is comprised of drug and medical device … [Read more...] about Three Canadian Life Sciences stocks to watch for 2020
Raymond James analyst Rahul Sarugaser thinks Profound Medical Corp (Profound Medical Corp Stock Quote, Chart, News TSX:PRN) is profoundly undervalued. … [Read more...] about Raymond James launches coverage of Profound Medical Corp with a $4.00 target
Investors should soon expect a breakout for Profound Medical Corp (Profound Medical Corp Stock Quote, Chart, News TSX:PRN) after the company’s … [Read more...] about Profound Medical is ready for a breakout, says Mackie Research
Upcoming catalysts are reason to get interested in medical device company Profound Medical (Profound Medical Stock Quote, Chart TSX:PRN), according to … [Read more...] about Profound Medical has 400 per cent upside, says Paradigm Capital
Profound Medical (Profound Medical Stock Quote, Chart TSX:PRN) is getting a huge target raise from Mackie Research analyst André Uddin on the back of … [Read more...] about Profound Medical gets a target raise from Mackie Research
2018 didn't shape up exactly the way he had imagined, but Echelon Wealth Partners analyst Doug Loe thinks 2019 could be Profound Medical's (Profound … [Read more...] about Profound Medical is an undervalued life sciences stock for 2019, Echelon says
